Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B Abelson

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 6, 1998
Evaluation of olopatadine, a new ophthalmic antiallergic agent with dual activity, using the conjunctival allergen challenge modelM B Abelson
Acta Ophthalmologica Scandinavica. Supplement|May 25, 1999
Comparison of the conjunctival allergen challenge model with the environmental model of allergic conjunctivitisM B Abelson
European Journal of Ophthalmology|April 1, 1994
Levocabastine eye drops: a new approach for the treatment of acute allergic conjunctivitisM B Abelson, D Weintraub
Advances in Experimental Medicine and Biology|January 1, 1994
Dry eye therapy: evaluation of current directions and clinical trialsM B Abelson, E Knight
International Ophthalmology Clinics|April 1, 1997
Atopic keratoconjunctivitisR Casey, M B Abelson
American Journal of Ophthalmology|June 30, 1998
Combined analysis of two studies using the conjunctival allergen challenge model to evaluate olopatadine hydrochloride, a new ophthalmic antiallergic agent with dual activityM B Abelson, L Spitalny
Survey of Ophthalmology|July 1, 1993
Conjunctivitis of allergic origin: immunologic mechanisms and current approaches to therapyM B Abelson, K Schaefer
The Journal of the Florida Medical Association|April 1, 1994
Nonsteroidal anti-inflammatory drugs. Current ophthalmic therapyM B Abelson, J Sloan
Acta Ophthalmologica Scandinavica. Supplement|November 1, 2000
An evaluation of onset and duration of action of patanol (olopatadine hydrochloride ophthalmic solution 0.1%) compared to Claritin (loratadine 10 mg) tablets in acute allergic conjunctivitis in the conjunctival allergen challenge modelM B Abelson, D L Welch
International Ophthalmology Clinics|January 1, 1977
Viral uveitisM B Abelson, D Pavan-Langston
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 6, 1998
Evaluation of olopatadine, a new ophthalmic antiallergic agent with dual activity, using the conjunctival allergen challenge modelM B Abelson
Acta Ophthalmologica Scandinavica. Supplement|May 25, 1999
Comparison of the conjunctival allergen challenge model with the environmental model of allergic conjunctivitisM B Abelson
European Journal of Ophthalmology|April 1, 1994
Levocabastine eye drops: a new approach for the treatment of acute allergic conjunctivitisM B Abelson, D Weintraub
Advances in Experimental Medicine and Biology|January 1, 1994
Dry eye therapy: evaluation of current directions and clinical trialsM B Abelson, E Knight
International Ophthalmology Clinics|April 1, 1997
Atopic keratoconjunctivitisR Casey, M B Abelson
American Journal of Ophthalmology|June 30, 1998
Combined analysis of two studies using the conjunctival allergen challenge model to evaluate olopatadine hydrochloride, a new ophthalmic antiallergic agent with dual activityM B Abelson, L Spitalny
Survey of Ophthalmology|July 1, 1993
Conjunctivitis of allergic origin: immunologic mechanisms and current approaches to therapyM B Abelson, K Schaefer
The Journal of the Florida Medical Association|April 1, 1994
Nonsteroidal anti-inflammatory drugs. Current ophthalmic therapyM B Abelson, J Sloan
Acta Ophthalmologica Scandinavica. Supplement|November 1, 2000
An evaluation of onset and duration of action of patanol (olopatadine hydrochloride ophthalmic solution 0.1%) compared to Claritin (loratadine 10 mg) tablets in acute allergic conjunctivitis in the conjunctival allergen challenge modelM B Abelson, D L Welch
International Ophthalmology Clinics|January 1, 1977
Viral uveitisM B Abelson, D Pavan-Langston
Pageof 8